Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric
Fresenius Kabi USA, LLC (Revised 05/08/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17) | Available | ||
| Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17) | Available | Check wholesalers for inventory | Demand increase for the drug |
| Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17) | Available | ||
| Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17) | Available | Check wholesaler inventory | |
| Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57) | Unavailable | Backordered. Next release May 2024. | Demand increase for the drug |
| Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27) | Available | Check wholesaler for inventory | |
| Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57) | Available | Check wholesaler inventory | |
| Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27) | Available | Check wholesalers for inventory | Demand increase for the drug |
| Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57) | Unavailable | Backordered. Next release June 2024. | Demand increase for the drug |
| Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37) | Available | Check wholesaler inventory | |
| Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37) | Available | Check wholesaler for inventory. | |
| Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27) | Available | Check wholesaler inventory |
Hospira, Inc., a Pfizer Company (Revised 05/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01) | Unavailable | Next Delivery: April 2025; Estimated Recovery: June 2025; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01) | Unavailable | Next Delivery and Estimated Recovery: June 2025; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02) | Unavailable | Next Delivery: August 2024; Estimated Recovery: March 2025; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03) | Unavailable | Next Delivery: February 2025; Estimated Recovery: June 2025 | Demand increase for the drug |
| Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01) | Available | ||
| Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01) | Unavailable | Next Delivery: January 2025; Estimated Recovery: March 2025; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01) | Unavailable | Next Delivery and Estimated Recovery: June 2025; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Lidocaine Hydrochloride And Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02) | Unavailable | Next Delivery: January 2025; Estimated Recovery: June 2025 | Demand increase for the drug |
| Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03) | Unavailable | Next Delivery and Estimated Recovery: June 2025; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |
| Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01) | Unavailable | Next Delivery: February 2025; Estimated Recovery: June 2025; Shortage per Manufacturer: Manufacturing Delay | Delay in shipping of the drug |